Nanodiagnosis and nanotreatment of colorectal cancer: an overview
Source abstract
Abstract
The most suitable strategy to improving the long-term viability of cancer patients and overcoming the high morbidity and severity of cancer is the precise identification of particular tumor markers related to cancer using non-invasive techniques. A suitable and immediate therapeutic action may result in the measurement of biomarkers at various phases of cancer. In this scope, the detection of biomarkers by various nanosensors is at the forefront of innovation into cancer diagnosis due to their specific features such as flexibility, rapid response, precise measurement, and multipathing and miniaturization processability. In this review, different nanobiosensors and several biomarkers were discussed for diagnosis of colorectal cancer. In the last few years, multifunctional nanostructured materials have shown a considerable potential to augment the efficacy, selectivity, specificity, and controlled release of various drugs for colorectal cancer treatment. Nanotechnology-based drug delivery systems hold enormous perspective to minimize systemic toxicity by the construction of modified nanomaterials for target-specific treatment. This review shed light on the current progress of various kinds of nanomaterials such as dendrimers, liposomes, micelles, lipid nanodiscs, nano-cubosomes, and nanoparticles for efficient drug delivery in the treatment of colorectal cancer.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Alam J, Alam S, Hossan A (2018) Multi-stage lung cancer detection and prediction using multi-class svm classifie. In: 2018 International Conference on Computer, Communication, Chemical, Material and Electronic Engineering (IC4ME2). IEEE10.1109/IC4ME2.2018.8465593 ↗
2. Allen TM, Cullis PR (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65(1):36–4810.1016/j.addr.2012.09.037 ↗
3. An N, Zhao C, Yu Z, Yang X (2019) Identification of prognostic genes in colorectal cancer through transcription profiling of multi-stage carcinogenesis. Oncol Lett 17(1):432–441
4. Anastopoulos I, Kyzas GZ (2015) Composts as biosorbents for decontamination of various pollutants: a review. Water, Air, Soil Pollut 226(3)10.1007/s11270-015-2345-2 ↗
5. Angell HK, Bruni D, Barrett JC, Herbst R, Galon J (2020) The immunoscore: colon cancer and beyond. Clin Cancer Res 26(2):332–33910.1158/1078-0432.CCR-18-1851 ↗
6. Angelov B, Angelova A, Garamus VM, Drechsler M, Willumeit R, Mutafchieva R, Štěpánek P, Lesieur S (2012) Earliest stage of the tetrahedral nanochannel formation in cubosome particles from unilamellar nanovesicles. Langmuir 28(48):16647–1665510.1021/la302721n ↗
7. Ansari MT, Ramlan TA, Jamaluddin NN, Zamri N, Salfi R, Khan A, Sami F, Majeed S, Hasnain MS (2020) Lipid-based nanocarriers for cancer and tumor treatment. Curr Pharm Des 26:4272–427610.2174/1381612826666200720235752 ↗
8. Araújo RVD et al (2018) New advances in general biomedical applications of PAMAM dendrimers. Molecules 23(11):284910.3390/molecules23112849 ↗
9. Armstrong A, Eck SL (2003) EpCAM: a new therapeutic target for an old cancer antigen. Cancer biology & therapy 2(4):320–32510.4161/cbt.2.4.451 ↗
10. Aydın M, Aydın EB, Sezgintürk MK (2018a) A disposable immunosensor using ITO based electrode modified by a star-shaped polymer for analysis of tumor suppressor protein p53 in human serum. Biosens Bioelectron 107:1–910.1016/j.bios.2018.02.017 ↗
11. Aydın M, Aydın EB, Sezgintürk MK (2018b) A highly selective electrochemical immunosensor based on conductive carbon black and star PGMA polymer composite material for IL-8 biomarker detection in human serum and saliva. Biosens Bioelectron 117:720–72810.1016/j.bios.2018.07.010 ↗
12. Aziz Mousavi SMA, Mirhosseini SA, Rastegar Shariat Panahi M, Mahmoodzadeh Hosseini H (2020) Characterization of biosynthesized silver nanoparticles using lactobacillus rhamnosus GG and its in vitro assessment against colorectal cancer cells. Probiotics and Antimicrobial Proteins 12(2):740–74610.1007/s12602-019-09530-z ↗
13. Bai Y, Wang Y, Zhang X, Fu J, Xing X, Wang C, Gao L, Liu Y, Shi L (2019) Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy. Int J Pharm 570:11863610.1016/j.ijpharm.2019.118636 ↗
14. Banerjee S, Pal TK, Guha SK (2012a) Probing molecular interactions of poly (styrene-co-maleic acid) with lipid matrix models to interpret the therapeutic potential of the co-polymer. Biochimica et Biophysica Acta (BBA)-Biomembranes 1818(3):537–55010.1016/j.bbamem.2011.12.010 ↗
15. Banerjee S, Sen K, Pal TK, Guha SK (2012b) Poly (styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy. Int J Pharm 436(1–2):786–79710.1016/j.ijpharm.2012.07.059 ↗
16. Baranei M, Taheri RA, Tirgar M, Saeidi A, Oroojalian F, Uzun L, Asefnejad A, Wurm FR, Goodarzi V (2020) Anticancer effect of green tea extract (GTE)-loaded pH-responsive niosome coated with PEG against different cell lines. Mater Today Commun:10175110.1016/j.mtcomm.2020.101751 ↗
17. Barani M, Mirzaei M, Torkzadeh-Mahani M, Nematollahi MH (2018) Lawsone-loaded niosome and its antitumor activity in MCF-7 breast Cancer cell line: a nano-herbal treatment for cancer. DARU J Pharm Sci 26(1):11–1710.1007/s40199-018-0207-3 ↗
18. Barani M et al (2019a) Evaluation of carum-loaded niosomes on breast cancer cells: physicochemical properties, In vitro cytotoxicity, flow cytometric, DNA fragmentation and cell migration assay. Sci Rep 9(1):1–1010.1038/s41598-019-43755-w ↗
19. Barani M, Nematollahi MH, Zaboli M, Mirzaei M, Torkzadeh-Mahani M, Pardakhty A, Karam GA (2019b) In silico and in vitro study of magnetic niosomes for gene delivery: the effect of ergosterol and cholesterol. Mater Sci Eng C 94:234–24610.1016/j.msec.2018.09.026 ↗
20. Barani M, Mirzaei M, Torkzadeh-Mahani M, Lohrasbi-Nejad A, Nematollahi MH (2020a) A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells. Mater Sci Eng C 113:11097510.1016/j.msec.2020.110975 ↗
21. Barani M, Sabir F, Rahdar A, Arshad R, Kyzas GZ (2020b) Nanotreatment and nanodiagnosis of prostate cancer: recent updates. Nanomaterials 10(9):169610.3390/nano10091696 ↗
22. Barani M et al (2020c) Comprehensive evaluation of gene expression in negative and positive trigger-based targeting niosomes in HEK-293 cell line. Iran J Pharm Res 19(1):166–180
23. Barauskas J, Johnsson M, Joabsson F, Tiberg F (2005) Cubic phase nanoparticles (cubosome): principles for controlling size, structure, and stability. Langmuir 21(6):2569–257710.1021/la047590p ↗
24. Barderas R, Bartolome RA, Fernandez-Acenero MJ, Torres S, Casal JI (2012) High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res 72(11):2780–279010.1158/0008-5472.CAN-11-4090 ↗
25. Bennouna J, Hiret S, Bertaut A, Bouché O, Deplanque G, Borel C, François E, Conroy T, Ghiringhelli F, des Guetz G, Seitz JF, Artru P, Hebbar M, Stanbury T, Denis MG, Adenis A, Borg C (2019) Continuation of bevacizumab vs cetuximab plus chemotherapy after first progression in KRAS wild-type metastatic colorectal cancer: the UNICANCER PRODIGE18 randomized clinical trial. JAMA Oncol 5(1):83–9010.1001/jamaoncol.2018.4465 ↗
26. Bilal M, Barani M, Sabir F, Rahdar A, Kyzas GZ (2020) Nanomaterials for the treatment and diagnosis of Alzheimer’s disease: an overview. NanoImpact 20:10025110.1016/j.impact.2020.100251 ↗
27. Bolat ZB, Islek Z, Demir BN, Yilmaz EN, Sahin F, Ucisik MH (2020) Curcumin-and Piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of Curcumin on HCT116 colorectal cancer model. Front Bioeng Biotechnol 8:5010.3389/fbioe.2020.00050 ↗
28. Bort G, Lux F, Dufort S, Crémillieux Y, Verry C, Tillement O (2020) EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX nanoparticles. Theranostics 10(3):1319–133110.7150/thno.37543 ↗
29. Bouchoucha M, Béliveau É, Kleitz F, Calon F, Fortin MA (2017) Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting. J Mater Chem B 5(37):7721–773510.1039/C7TB01385J ↗
30. Bravo K, Ortega FG, Messina GA, Sanz MI, Fernández-Baldo MA, Raba J (2017) Integrated bio-affinity nano-platform into a microfluidic immunosensor based on monoclonal bispecific trifunctional antibodies for the electrochemical determination of epithelial cancer biomarker. Clin Chim Acta 464:64–7110.1016/j.cca.2016.11.012 ↗
31. Buabeid MA, Arafa E-SA, Murtaza G (2020) Emerging prospects for nanoparticle-enabled cancer immunotherapy. J Immunol Res 2020:1–1110.1155/2020/9624532 ↗
32. Campuzano S, Yáñez-Sedeño P, Pingarrón JM (2019) Carbon dots and graphene quantum dots in electrochemical biosensing. Nanomaterials 9(4):63410.3390/nano9040634 ↗
33. Carneiro FP et al (2019) Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash. Oncol Lett 18(2)10.3892/ol.2019.10468 ↗
34. Carvalho MR, Carvalho CR, Maia FR, Caballero D, Kundu SC, Reis RL, Oliveira JM (2019) Peptide-modified dendrimer nanoparticles for targeted therapy of colorectal cancer. Advanced Therapeutics 2(11):190013210.1002/adtp.201900132 ↗
35. Carvalho M, Reis R, Oliveira JM (2020) Dendrimer nanoparticles for colorectal cancer applications. J Mater Chem B 8(6):1128–113810.1039/C9TB02289A ↗
36. Chan H-N, Xu D, Ho SL, He D, Wong MS, Li HW (2019) Highly sensitive quantification of Alzheimer’s disease biomarkers by aptamer-assisted amplification. Theranostics 9(10):2939–294910.7150/thno.29232 ↗
37. Chang J, Wang X, Wang J, Li H, Li F (2019) Nucleic acid-functionalized metal–organic framework-based homogeneous electrochemical biosensor for simultaneous detection of multiple tumor biomarkers. Anal Chem 91(5):3604–361010.1021/acs.analchem.8b05599 ↗
38. Chen L, She X, Wang T, He L, Shigdar S, Duan W, Kong L (2015) Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles. Nanoscale 7(33):14080–1409210.1039/C5NR03527A ↗
39. Chen Y, Zhou S, Li L, Zhu JJ (2017) Nanomaterials-based sensitive electrochemiluminescence biosensing. Nano Today 12:98–11510.1016/j.nantod.2016.12.013 ↗
40. Chen S-Q et al (2020) Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Carbohydr Polym 230:11561310.1016/j.carbpol.2019.115613 ↗
41. Cortese K, Marconi S, Aiello C, Gagliani MC, Pilato S, Zappacosta R, Fontana A, Castagnola P (2020) Liposomes loaded with the proteasome inhibitor Z-leucinyl-leucinyl-norleucinal are effective in inducing apoptosis in colorectal cancer cell lines. Membranes 10(5):9110.3390/membranes10050091 ↗
42. Cubiella J, Marzo-Castillejo M, Mascort-Roca JJ, Amador-Romero FJ, Bellas-Beceiro B, Clofent-Vilaplana J, Carballal S, Ferrándiz-Santos J, Gimeno-García AZ, Jover R, Mangas-Sanjuán C, Moreira L, Pellisè M, Quintero E, Rodríguez-Camacho E, Vega-Villaamil P (2018) Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update. Gastroenterología y Hepatología (English Edition) 41(9):585–59610.1016/j.gastre.2018.07.008 ↗
43. Dai L, Tsay JCJ, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY (2016) Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer 99:172–17910.1016/j.lungcan.2016.07.018 ↗
44. Das SS, Bharadwaj P, Bilal M, Barani M, Rahdar A, Taboada P, Bungau S, Kyzas GZ (2020) Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers 12(6):139710.3390/polym12061397 ↗
45. Davarpanah F, Khalili Yazdi A, Barani M, Mirzaei M, Torkzadeh-Mahani M (2018) Magnetic delivery of antitumor carboplatin by using PEGylated-niosomes. DARU J Pharm Sci 26(1):57–6410.1007/s40199-018-0215-3 ↗
46. Davarpanah AM, Rahdar A, Dastnae MA, Zeybek O, Beyzaei H (2019) (1-x) BaFe12O19/xCoFe2O4 hard/soft magnetic nanocomposites: synthesis, physical characterization, and antibacterial activities study. J Mol Struct 1175:445–44910.1016/j.molstruc.2018.07.092 ↗
47. Deliyanni EA, Kyzas GZ, Matis KA (2017) Various flotation techniques for metal ions removal. J Mol Liq 225:260–26410.1016/j.molliq.2016.11.069 ↗
48. Duan X, Wang P, Men K, Gao X, Huang MJ, Gou ML, Chen LJ, Qian ZY, Wei YQ (2012) Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG–PCL micelles. Nanoscale 4(7):2400–240710.1039/c2nr30079f ↗
49. Ebrahim SA et al (2020) Publication trends in exosomes nanoparticles for cancer detection. Int J Nanomedicine 15:4453–447010.2147/IJN.S247210 ↗
50. Ebrahimi AK, Barani M, Sheikhshoaie I (2018) Fabrication of a new superparamagnetic metal-organic framework with core-shell nanocomposite structures: characterization, biocompatibility, and drug release study. Mater Sci Eng C 92:349–35510.1016/j.msec.2018.07.010 ↗
51. Elahi N, Kamali M, Baghersad MH (2018) Recent biomedical applications of gold nanoparticles: a review. Talanta 184:537–55610.1016/j.talanta.2018.02.088 ↗
52. Elahi N, Kamali M, Baghersad MH, Amini B (2019) A fluorescence nano-biosensors immobilization on iron (MNPs) and gold (AuNPs) nanoparticles for detection of Shigella spp. Mater Sci Eng C 105:11011310.1016/j.msec.2019.110113 ↗
53. El-Aneed A (2004) An overview of current delivery systems in cancer gene therapy. J Control Release 94(1):1–1410.1016/j.jconrel.2003.09.013 ↗
54. El-Bassuony AA (2020a) Influence of high annealing temperature on structural, magnetic and antimicrobial activity of silver chromite nanoparticles for biomedical applications. J Inorg Organomet Polym Mater 30(5):1821–182810.1007/s10904-019-01306-w ↗
55. El-Bassuony AA (2020b) Effect of Al addition on structural, magnetic, and antimicrobial properties of Ag nanoparticles for biomedical applications. JOM 72(3):1154–116210.1007/s11837-019-03784-2 ↗
56. El-Bassuony AA, Abdelsalam H (2020a) Correlation of heat treatment and the impurities accompanying Ag nanoparticles. Eur Phys J Plus 135(1):6610.1140/epjp/s13360-019-00025-y ↗
57. El-Bassuony AA, Abdelsalam H (2020b) Impacts of hematite, bunsenite and maghemite impurities on the physical and antimicrobial properties of silver nanoparticles. Eur Phys J Plus 135(1):1–1710.1140/epjp/s13360-020-00139-8 ↗
58. El-Bassuony AA, Abdelsalam H (2020c) Synthesis, characterization, magnetic and antimicrobial properties of silver chromite nanoparticles. J Mater Sci Mater Electron 31(4):3662–367310.1007/s10854-020-02924-8 ↗
59. Fadaka AO, Pretorius A, Klein A (2019) Biomarkers for stratification in colorectal cancer: microRNAs. Cancer Control 26(1):107327481986278410.1177/1073274819862784 ↗
60. Fanelli GN et al (2020) The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer. Cancer Cell Int 20(1):1–1210.1186/s12935-020-1117-2 ↗
61. Farka Z, Juřík T, Kovář D, Trnková L, Skládal P (2017) Nanoparticle-based immunochemical biosensors and assays: recent advances and challenges. Chem Rev 117(15):9973–1004210.1021/acs.chemrev.7b00037 ↗
62. Gabizon AA et al (2020) Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients. Investig New Drugs:1–1010.1007/s10637-020-00897-3 ↗
63. Gao Y, Xie X, Li F, Lu Y, Li T, Lian S, Zhang Y, Zhang H, Mei H, Jia L (2017) A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin. Nanoscale 9(17):5624–564010.1039/C7NR00273D ↗
64. Gatoo MA et al (2014) Physicochemical properties of nanomaterials: implication in associated toxic manifestations. Biomed Res Int 2014:49842010.1155/2014/498420 ↗
65. Ge P, Niu B, Wu Y, Xu W, Li M, Sun H, Zhou H, Zhang X, Xie J (2020) Enhanced cancer therapy of celastrol in vitro and in vivo by smart dendrimers delivery with specificity and biosafety. Chem Eng J 383:12322810.1016/j.cej.2019.123228 ↗
66. Gholami, Y.H. and A. Engel, Theranostic nanoplatforms for treatment and diagnosis of rectal and colon cancer: a brief review. 201810.20517/2574-1225.2018.44 ↗
67. Gulati P, Mishra P, Khanuja M, Narang J, Islam SS (2020) Nano-moles detection of tumor specific biomarker DNA for colorectal cancer detection using vertically aligned multi-wall carbon nanotubes based flexible electrodes. Process Biochem 90:184–19210.1016/j.procbio.2019.11.021 ↗
68. Guo S, Piao X, Li H, Guo P (2018) Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor. Methods 143:121–13310.1016/j.ymeth.2018.02.025 ↗
69. Guo J, Yu Z, Das M, Huang L (2020) Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis. ACS Nano 14(4):5075–508910.1021/acsnano.0c01676 ↗
70. Hajizadeh MR, Maleki H, Barani M, Fahmidehkar MA, Mahmoodi M, Torkzadeh-Mahani M (2019a) In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents. Res Pharm Sci 14(5):448–45810.4103/1735-5362.268206 ↗
71. Hajizadeh MR, Parvaz N, Barani M, Khoshdel A, Fahmidehkar MA, Mahmoodi M, Torkzadeh-Mahani M (2019b) Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay. DARU J Pharm Sci 27(1):329–33910.1007/s40199-019-00277-0 ↗
72. Han S et al (2008) CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-β signaling. Oncogene 27(5):675–68310.1038/sj.onc.1210686 ↗
73. Hao N, Zhang JX (2018) Microfluidic screening of circulating tumor biomarkers toward liquid biopsy. Separation & Purification Reviews 47(1):19–4810.1080/15422119.2017.1320763 ↗
74. Hashiguchi Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–4210.1007/s10147-019-01485-z ↗
75. Hashkavayi AB, Raoof JB, Ojani R, Kavoosian S (2017) Ultrasensitive electrochemical aptasensor based on sandwich architecture for selective label-free detection of colorectal cancer (CT26) cells. Biosens Bioelectron 92:630–63710.1016/j.bios.2016.10.042 ↗
76. He Z, Cheng X, Kyzas GZ, Fu J (2016) Pharmaceuticals pollution of aquaculture and its management in China. J Mol Liq 223:781–78910.1016/j.molliq.2016.09.005 ↗
77. Hu Y, He Y, Ji J, Zheng S, Cheng Y (2020) Tumor targeted curcumin delivery by folate-modified MPEG-PCL self-assembly micelles for colorectal cancer therapy. Int J Nanomedicine 15:1239–125210.2147/IJN.S232777 ↗
78. Huang L, Huang J, Huang J, Xue H, Liang Z, Wu J, Chen C (2020) Nanomedicine–a promising therapy for hematological malignancies. Biomater Sci 8(9):2376–239310.1039/D0BM00129E ↗
79. Jalalian SH, Taghdisi SM, Shahidi Hamedani N, Kalat SAM, Lavaee P, ZandKarimi M, Ghows N, Jaafari MR, Naghibi S, Danesh NM, Ramezani M, Abnous K (2013) Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo. Eur J Pharm Sci 50(2):191–19710.1016/j.ejps.2013.06.015 ↗
80. Jing A, Zhang C, Liang G, Feng W, Tian Z, Jing C (2018) Hyaluronate-functionalized graphene for label-free electrochemical cytosensing. Micromachines 9(12):66910.3390/mi9120669 ↗
81. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS (2011) Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6(4):715–72810.2217/nnm.11.19 ↗
82. Kanat O, Ertas H (2019) Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy. World J Clin Oncol 10(2):52–6110.5306/wjco.v10.i2.52 ↗
83. Kim JU, Shariff MIF, Crossey MME, Gomez-Romero M, Holmes E, Cox IJ, Fye HKS, Njie R, Taylor-Robinson SD (2016) Hepatocellular carcinoma: review of disease and tumor biomarkers. World J Hepatol 8(10):471–48410.4254/wjh.v8.i10.471 ↗
84. Kim S, Lee SY, Cho H-J (2017) Doxorubicin-wrapped zinc oxide nanoclusters for the therapy of colorectal adenocarcinoma. Nanomaterials 7(11):35410.3390/nano7110354 ↗
85. Klement RJ, Abbasi-Senger N, Adebahr S, Alheid H, Allgaeuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Eble MJ, Ernst I, Gerum S, Habermehl D, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lewitzki V, Lohaus F, Ostheimer C, Papachristofilou A, Petersen C, Rieber J, Schneider T, Schrade E, Semrau R, Wachter S, Wittig A, Guckenberger M, Andratschke N (2019) The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases. BMC Cancer 19(1):17310.1186/s12885-019-5362-5 ↗
86. Koliarakis I, Messaritakis I, Nikolouzakis TK, Hamilos G, Souglakos J, Tsiaoussis J (2019) Oral bacteria and intestinal dysbiosis in colorectal cancer. Int J Mol Sci 20(17):414610.3390/ijms20174146 ↗
87. Konishi T, Shimada Y, Hsu M, Tufts L, Jimenez-Rodriguez R, Cercek A, Yaeger R, Saltz L, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, Gonen M, Weiser MR (2018) Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome. JAMA Oncol 4(3):309–31510.1001/jamaoncol.2017.4420 ↗
88. Kuai R, Ochyl LJ, Bahjat KS, Schwendeman A, Moon JJ (2017) Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat Mater 16(4):489–49610.1038/nmat4822 ↗
89. Kuai R et al (2018) Elimination of established tumors with nanodisc-based combination chemoimmunotherapy. Sci Adv 4(4):eaao173610.1126/sciadv.aao1736 ↗
90. Kumar P, Tambe P, Paknikar KM, Gajbhiye V (2018) Mesoporous silica nanoparticles as cutting-edge theranostics: advancement from merely a carrier to tailor-made smart delivery platform. J Control Release 287:35–5710.1016/j.jconrel.2018.08.024 ↗
91. Kurtz DM et al (2019) Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell 178(3):699–713. e1910.1016/j.cell.2019.06.011 ↗
92. Kyzas GZ, Matis KA (2016) Electroflotation process: a review. J Mol Liq 220:657–66410.1016/j.molliq.2016.04.128 ↗
93. Kyzas GZ, Lazaridis NK, Kostoglou M (2014) Adsorption/desorption of a dye by a chitosan derivative: experiments and phenomenological modeling. Chem Eng J 248:327–33610.1016/j.cej.2014.03.063 ↗
94. Kyzas GZ, Bomis G, Kosheleva RI, Efthimiadou EK, Favvas EP, Kostoglou M, Mitropoulos AC (2019) Nanobubbles effect on heavy metal ions adsorption by activated carbon. Chem Eng J 356:91–9710.1016/j.cej.2018.09.019 ↗
95. Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K, International Agency for Research on Cancer Handbook Working Group (2018) The IARC perspective on colorectal cancer screening. N Engl J Med 378(18):1734–174010.1056/NEJMsr1714643 ↗
96. Lee H, Yu MK, Park S, Moon S, Min JJ, Jeong YY, Kang HW, Jon S (2007) Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc 129(42):12739–1274510.1021/ja072210i ↗
97. Lee Y et al (2012) Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer 106(11):1833–184110.1038/bjc.2012.177 ↗
98. Lee KM et al (2018) Chemical design of functional polymer structures for biosensors: from nanoscale to macroscale. Polymers 10(5):55110.3390/polym10050551 ↗
99. Lew J-B et al (2019) Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health Res Pract 29(2)10.17061/phrp2921913 ↗
100. Li H-J, du JZ, du XJ, Xu CF, Sun CY, Wang HX, Cao ZT, Yang XZ, Zhu YH, Nie S, Wang J (2016) Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. Proc Natl Acad Sci 113(15):4164–416910.1073/pnas.1522080113 ↗